OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response
Yan Jia, Xiu ling Deng, Qi Shi, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Yan Jia, Xiu ling Deng, Qi Shi, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Showing 6 citing articles:
The current status and future of PD-L1 in liver cancer
Liyuan Hao, Shenghao Li, Jiali Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Liyuan Hao, Shenghao Li, Jiali Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression
Liqin Ruan, Ningbo Fang, Xinhua Zhao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Liqin Ruan, Ningbo Fang, Xinhua Zhao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Magnesium cantharidate inhibits hepatocellular cancer by targeting RACK1
Da Sun, Xiaofei Li, Meichen Liu, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1178-1199
Closed Access
Da Sun, Xiaofei Li, Meichen Liu, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1178-1199
Closed Access
Norcantharidin inhibits TOP2A expression via H3K27me3 mediated epigenetic regulation to alleviate the progression of hepatocellular carcinoma
Ruibing Wu, Hailong Yuan, Yuehua Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Ruibing Wu, Hailong Yuan, Yuehua Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment
Xie Ruishi, Xu Linyi, Bai Yunfan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Xie Ruishi, Xu Linyi, Bai Yunfan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Identification of target genes co-regulated by four key histone modifications of five key regions in hepatocellular carcinoma
Yu-Xian Liu, Jia‐Le Song, Xiaoming Li, et al.
Methods (2024)
Closed Access | Times Cited: 1
Yu-Xian Liu, Jia‐Le Song, Xiaoming Li, et al.
Methods (2024)
Closed Access | Times Cited: 1
